Cytosorbents Corp
NASDAQ:CTSO

Watchlist Manager

Cytosorbents Corp

NASDAQ:CTSO

Watchlist

Price: 1.42 USD Market Closed

Market Cap: 77.1m USD

Have any thoughts about
Cytosorbents Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 1.42 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CTSO Alert

Cytosorbents Corp

1.42

0.00 (0%)

52 Week Range	0.7 2.02
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Cytosorbents Corp

What unique competitive advantages
does Cytosorbents Corp hold over its rivals?

What risks and challenges
does Cytosorbents Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Cytosorbents Corp.

What unique competitive advantages
does Cytosorbents Corp hold over its rivals?

What risks and challenges
does Cytosorbents Corp face in the near future?

Has there been any significant insider trading activity
in Cytosorbents Corp recently?

Summarize the latest earnings call
of Cytosorbents Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cytosorbents Corp.

Provide P/S
for Cytosorbents Corp.

Provide P/E
for Cytosorbents Corp.

Provide P/OCF
for Cytosorbents Corp.

Provide P/FCFE
for Cytosorbents Corp.

Provide P/B
for Cytosorbents Corp.

Provide EV/S
for Cytosorbents Corp.

Provide EV/GP
for Cytosorbents Corp.

Provide EV/EBITDA
for Cytosorbents Corp.

Provide EV/EBIT
for Cytosorbents Corp.

Provide EV/OCF
for Cytosorbents Corp.

Provide EV/FCFF
for Cytosorbents Corp.

Provide EV/IC
for Cytosorbents Corp.

Show me price targets
for Cytosorbents Corp made by professional analysts.

What are the Revenue projections
for Cytosorbents Corp?

How accurate were the past Revenue estimates
for Cytosorbents Corp?

What are the Net Income projections
for Cytosorbents Corp?

How accurate were the past Net Income estimates
for Cytosorbents Corp?

What are the EPS projections
for Cytosorbents Corp?

How accurate were the past EPS estimates
for Cytosorbents Corp?

What are the EBIT projections
for Cytosorbents Corp?

How accurate were the past EBIT estimates
for Cytosorbents Corp?

Compare the revenue forecasts
for Cytosorbents Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cytosorbents Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cytosorbents Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cytosorbents Corp compared to its peers.

Compare the P/E ratios
of Cytosorbents Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Cytosorbents Corp with its peers.

Analyze the financial leverage
of Cytosorbents Corp compared to its main competitors.

Show all profitability ratios
for Cytosorbents Corp.

Provide ROE
for Cytosorbents Corp.

Provide ROA
for Cytosorbents Corp.

Provide ROIC
for Cytosorbents Corp.

Provide ROCE
for Cytosorbents Corp.

Provide Gross Margin
for Cytosorbents Corp.

Provide Operating Margin
for Cytosorbents Corp.

Provide Net Margin
for Cytosorbents Corp.

Provide FCF Margin
for Cytosorbents Corp.

Show all solvency ratios
for Cytosorbents Corp.

Provide D/E Ratio
for Cytosorbents Corp.

Provide D/A Ratio
for Cytosorbents Corp.

Provide Interest Coverage Ratio
for Cytosorbents Corp.

Provide Altman Z-Score Ratio
for Cytosorbents Corp.

Provide Quick Ratio
for Cytosorbents Corp.

Provide Current Ratio
for Cytosorbents Corp.

Provide Cash Ratio
for Cytosorbents Corp.

What is the historical Revenue growth
over the last 5 years for Cytosorbents Corp?

What is the historical Net Income growth
over the last 5 years for Cytosorbents Corp?

What is the current Free Cash Flow
of Cytosorbents Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cytosorbents Corp.

P/E
Price to Earnings

-3

Current

-2.8

Median

22.4

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

-3

Market Cap

77.1m USD

Net Income

-25.5m USD

All Countries

Forward Multiples

		Market Cap	P/E
US	Cytosorbents Corp NASDAQ:CTSO	77.1m USD	-3
US	Abbott Laboratories NYSE:ABT	198.6B USD	35.7
US	Intuitive Surgical Inc NASDAQ:ISRG	174.1B USD	83.2
US	Stryker Corp NYSE:SYK	139.1B USD	40.3
US	Boston Scientific Corp NYSE:BSX	123.1B USD	67.3
IE	Medtronic PLC NYSE:MDT	114.7B USD	29.2
US	Becton Dickinson and Co NYSE:BDX	67.8B USD	48
DE	Siemens Healthineers AG XETRA:SHL	55.5B EUR	29.8
US	IDEXX Laboratories Inc NASDAQ:IDXX	42.6B USD	50.4
US	GE Healthcare Technologies Inc NASDAQ:GEHC	41.4B USD	26.2
US	Edwards Lifesciences Corp NYSE:EW	40.5B USD	27.5

			Earnings Growth
US	Cytosorbents Corp NASDAQ:CTSO	Average P/E: 43.8 Negative Multiple: -3	N/A
US	Abbott Laboratories NYSE:ABT	35.7	73%
US	Intuitive Surgical Inc NASDAQ:ISRG	83.2	80%
US	Stryker Corp NYSE:SYK	40.3	81%
US	Boston Scientific Corp NYSE:BSX	67.3	191%
IE	Medtronic PLC NYSE:MDT	29.2	122%
US	Becton Dickinson and Co NYSE:BDX	48	218%
DE	Siemens Healthineers AG XETRA:SHL	29.8	118%
US	IDEXX Laboratories Inc NASDAQ:IDXX	50.4	38%
US	GE Healthcare Technologies Inc NASDAQ:GEHC	26.2	77%
US	Edwards Lifesciences Corp NYSE:EW	27.5	41%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

-4.3

2-Years Forward

P/E

-8.1

3-Years Forward

P/E

-38

Cytosorbents Corp
NASDAQ:CTSO

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Cytosorbents Corp NASDAQ:CTSO

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Cytosorbents Corp
NASDAQ:CTSO

P/E
Price to Earnings